Scarica l'app Stockscreener
1.06
6.14%
0.0613
Dopo l'orario di chiusura:
1.05
-0.01
-0.94%
Lunai Bioworks Inc Borsa (LNAI) Ultime notizie
Lunai bioworks identifies three parkinsons disease subtypes By Investing.com - Investing.com South Africa
Lunai bioworks identifies three parkinsons disease subtypes - Investing.com
Lunai Bioworks identifies three Parkinson's disease subtypes - marketscreener.com
Lunai Bioworks Identifies Three Parkinson's Subtypes and Prioritized Drug Targets to Accelerate Proof-of-Concept Programs and Strategic Partnerships in a $13B Market - Barchart.com
Ready to Jump After Recent Trade: Lunai Bioworks Inc (LNAI) - setenews.com
Lunai Bioworks (LNAI) Stock Analysis Report | Financials & Insights - Benzinga
Lunai Bioworks enters sales agreement with Dawson James SecuritiesSEC filing - marketscreener.com
Lunai Bioworks Enters Sales Agreement with Dawson James - TipRanks
Does Lunai Bioworks Inc (LNAI) offer a good opportunity for investors? - Setenews
Lunai Bioworks’ immune cell therapy shows tumor regression, wins first license - MSN
Lunai Bioworks stock soars after securing first licensing deal for cancer therapy - MSN
Lunai Bioworks - The Pharma Letter
Lunai Bioworks lands first licensing deal for off-the-shelf cancer immunotherapy - The Pharma Letter
There is no way Lunai Bioworks Inc (LNAI) can keep these numbers up - Setenews
Lunai Bioworks Secures $3.1M in Private Placement - The Globe and Mail
Lunai Bioworks Inc (2Q50.MU) latest stock news and headlines - Yahoo Finance Australia
Lunai Bioworks Inc. (LNAI) -7.5% in After-hours: Shares Decline Amidst New Licensing Agreement - Stocks Telegraph
Lunai Bioworks sells 3,133,333 shares in private financing deal - Stock Titan
LNAI Stock: Surging or Slipping? - StocksToTrade
Lunai Bioworks (LNAI) Stock: Plummets 14.2% Despite Breakthrough in Cancer Immunotherapy - parameter.io
Lunai Bioworks Shares Rise After Company Secures Licensing Intent for Dendritic Cell Therapy - marketscreener.com
Lunai Bioworks: Stock Surge or Bubble? - timothysykes.com
Lunai Bioworks stock soars after securing first licensing deal for cancer therapy By Investing.com - Investing.com South Africa
LNAI's Groundbreaking Immune Cell Therapy Advances with Key Lice - GuruFocus
Lunai Bioworks Secures First Licensing LOI Following Breakthrough Showing Complete Tumor Regression in Humanized Cancer Models - MarketScreener
Lunai Bioworks Secures First Licensing LOI Following Landmark Breakthrough Showing Complete Tumor Regression in Humanized Cancer Models - Sahm
Lunai Bioworks rises on early licensing interest in DCCT therapy | Tap to know more | Inshorts - Inshorts
Lunai Bioworks Inc. (LNAI) -7.5% in After-hours: Routine Trading Amid Price Decline - Stocks Telegraph
Lunai Bioworks Inc (2Q50.MU) options chain - Yahoo Finance Australia
Lunai Bioworks Inc. (LNAI) -13.9% in Normal Trading: Price Declines Amid Routine Trading - Stocks Telegraph
What is the current Price Target and Forecast for Lunai Bioworks Inc. (LNAI) - Zacks Investment Research
Lunai Bioworks Inc. announced that it expects to receive $3.133333 million in funding - marketscreener.com
Lunai Bioworks Inc Com (LNAI) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Lunai Bioworks Inc (2Q50.MU) analyst ratings, estimates and forecasts - Yahoo Finance Australia
Lunai Bioworks Inc (2Q50.MU) Valuation Measures & Financial Statistics - Yahoo! Finance Canada
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Are Smart Investors Making the Right Decision? Lunai Bioworks Inc (LNAI) - Setenews
Lunai Bioworks Inc. Unveils Transformer Platform to Secure Generative AI and Accelerate Drug Discovery - Greenville Online
Lunai Bioworks Inc. (LNAI) stock price, news, quote and history - Yahoo Finance Australia
Lunai Bioworks: Fiscal Q1 Earnings Snapshot - New Haven Register
Lunai Bioworks Inc. Reports Earnings Results for the First Quarter Ended September 30, 2025 - MarketScreener
[10-Q] Lunai Bioworks Inc. Quarterly Earnings Report | RENB SEC FilingForm 10-Q - Stock Titan
A better buy-in window may exist right now for Lunai Bioworks Inc (LNAI) - Setenews
A Mandatory Rebranding: Lunai Bioworks Emerges from Enochian’s Ashes - Ad-hoc-news.de
Lunai Bioworks Inc. (2Q50.F) Company Profile & Facts - Yahoo! Finance Canada
Lunai Bioworks Inc. (LNAI) Stock Major Holders - Yahoo! Finance Canada
Top Biotech Stocks To Follow NowNovember 5th - MarketBeat
Lunai Bioworks Inc. (LNAI) Stock Forecast & Price Prediction 2025–2030 - CoinCodex
Lunai Bioworks Inc. (LNAI) latest press releases and corporate news - Yahoo Finance UK
Top Biotech Stocks To Follow Now – November 5th - Defense World
Lunai Bioworks Inc (2Q50.MU) Latest Press Releases & Corporate News - Yahoo! Finance Canada
[8-K] Lunai Bioworks Inc. Reports Material Event | RENB SEC FilingForm 8-K - Stock Titan
Lunai Bioworks Inc. (LNAI) stock historical prices and data - Yahoo Finance UK
Lunai Bioworks Inc. (LNAI) interactive stock chart - Yahoo Finance UK
Lunai Bioworks Inc. (LNAI) Stock Price, News, Quote & History - Yahoo! Finance Canada
0.39%
1.90%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):